Wilbert Bannenberg Technical Director International MeTA Secretariat 5 September 2009, FIP 2009 Congress, Istanbul Medicin...
What is MeTA? <ul><li>An international alliance between: </li></ul><ul><ul><li>DFID, World Bank, WHO, private sector, NGOs...
What does MeTA want to achieve?  <ul><li>MeTA goal: to  increase access to essential medicines,  especially for the poor i...
Added value of MeTA? <ul><li>Country led, bottom-up approach </li></ul><ul><li>Multi-stakeholder collaboration </li></ul><...
The scope of MeTA  <ul><li>Currently 7 countries are piloting MeTA (until September 2010) </li></ul><ul><li>Global collabo...
Transparency? <ul><li>Improving information access, scrutiny and use, in order to support the development of viable, effic...
Drug Supply – Transparent? Source: SSDS Inc for the World Bank
Transparent? 05/09/2009 MeTA FIP Source: TI Global corruption report 2006
Areas where transparency can help… 05/09/2009 MeTA FIP Source: TI Global corruption report 2006
Transparency in pharmacy practice? <ul><li>Transparency  should be an integral part of Good Pharmacy Practice! </li></ul><...
Contact? <ul><li>Wilbert Bannenberg </li></ul><ul><li>[email_address] </li></ul><ul><li>Mobile: +31-6-20873123 </li></ul><...
Upcoming SlideShare
Loading in...5
×

MeTA introduction

680

Published on

Presentation by Wilbert Bannenberg, Technical Director, International MeTA Secretariat on MeTA during the 69th FIP Congress, Istanbul, September 2009.

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
680
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
6
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide
  • Title of presentation 21/01/10 MeTA
  • Title of presentation 21/01/10 MeTA
  • Title of presentation 21/01/10 MeTA
  • Title of presentation 21/01/10 MeTA
  • Title of presentation 21/01/10 MeTA
  • Title of presentation 21/01/10 MeTA
  • MeTA introduction

    1. 1. Wilbert Bannenberg Technical Director International MeTA Secretariat 5 September 2009, FIP 2009 Congress, Istanbul Medicines Transparency Alliance (MeTA) MeTA FIP 05/09/2009
    2. 2. What is MeTA? <ul><li>An international alliance between: </li></ul><ul><ul><li>DFID, World Bank, WHO, private sector, NGOs, professional organisations. </li></ul></ul><ul><li>Alliances in 7 pilot countries to focus on what can be done to increase access to medicines. </li></ul><ul><ul><li>- Government, CSOs and Private Sector </li></ul></ul><ul><li>An International Secretariat to support country work, and, upon request, technical assistance. </li></ul>05/09/2009 MeTA FIP
    3. 3. What does MeTA want to achieve? <ul><li>MeTA goal: to increase access to essential medicines, especially for the poor in developing countries </li></ul><ul><li>Essential medicines still valid concept </li></ul><ul><li>But, after 30 years, 2 billion people are still not having access </li></ul><ul><li>What can we do better? </li></ul>05/09/2009 MeTA FIP
    4. 4. Added value of MeTA? <ul><li>Country led, bottom-up approach </li></ul><ul><li>Multi-stakeholder collaboration </li></ul><ul><li>Improved transparency and disclosure of all players should lead to better information & greater accountability in the supply chain </li></ul>05/09/2009 MeTA FIP
    5. 5. The scope of MeTA <ul><li>Currently 7 countries are piloting MeTA (until September 2010) </li></ul><ul><li>Global collaboration with private sector, NGOs, donors and professional organisations </li></ul>05/09/2009 MeTA FIP
    6. 6. Transparency? <ul><li>Improving information access, scrutiny and use, in order to support the development of viable, efficient medicines markets and supply systems that benefit all developing country consumers </li></ul><ul><li>Transparency = not only disclosure of the price, quality of medicines; but also: </li></ul><ul><ul><li>Jointly use the information to identify barriers, and </li></ul></ul><ul><ul><li>Jointly seek better solutions! </li></ul></ul>MeTA FIP 05/09/2009
    7. 7. Drug Supply – Transparent? Source: SSDS Inc for the World Bank
    8. 8. Transparent? 05/09/2009 MeTA FIP Source: TI Global corruption report 2006
    9. 9. Areas where transparency can help… 05/09/2009 MeTA FIP Source: TI Global corruption report 2006
    10. 10. Transparency in pharmacy practice? <ul><li>Transparency should be an integral part of Good Pharmacy Practice! </li></ul><ul><li>Pharmacists can help in both public and private sector </li></ul><ul><li>Welcome in MeTA! </li></ul>05/09/2009 MeTA FIP
    11. 11. Contact? <ul><li>Wilbert Bannenberg </li></ul><ul><li>[email_address] </li></ul><ul><li>Mobile: +31-6-20873123 </li></ul><ul><li>MeTA website: www.MedicinesTransparency.org </li></ul>MeTA FIP 05/09/2009
    1. A particular slide catching your eye?

      Clipping is a handy way to collect important slides you want to go back to later.

    ×